West Pharmaceutical (WST) is down -23.3%, or -$75.07 to $247.21.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on WST:
- West Pharmaceutical Services: Strong Q4 Performance and Strategic Positioning Justify Buy Rating Despite FY25 Challenges
- West Pharmaceutical Services Sees Q4 Sales Growth in 2024
- West Pharmaceutical sees FY25 adjusted EPS $6.00-$6.20, consensus $7.43
- West Pharmaceutical reports Q4 adjusted EPS $1.82, consensus $1.73
- Is WST a Buy, Before Earnings?